SCHEMBL457447

SCHEMBL457447

O=C1C(=NNC(=S)Nc2c(F)cc(F)cc2F)Nc2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
KMT2A Q03164 6/20 0.33
MAPT P10636 6/20 0.33
ALDH1A1 P00352 5/20 0.33
MEN1 O00255 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
TYR P14679 1/20 0.32
NPC1 O15118 3/20 0.32
LRRK2 Q5S007 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
AGTR1 P30556 1/20 0.32
KDR P35968 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 2/20 0.32
RAB9A P51151 2/20 0.32
FLT3 P36888 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL469979 0.84 LRRK2 (0.45) KMT2AMAPTMEN1KDM4ENPC1
SCHEMBL456638 0.84 MAOA (0.34) MAOAMAOBKMT2AMAPTALDH1A1
SCHEMBL2877863 0.83 ALDH1A1 (0.46) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL2877739 0.76 MAPT (0.51) MAOAMAOBKMT2AMAPTALDH1A1
SCHEMBL456909 0.76 BCHE (0.43) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL456490 0.76 KDM4E (0.43) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL456579 0.74 ALDH1A1 (0.51) KMT2AMAPTALDH1A1MEN1TDP1
SCHEMBL456344 0.74 KMT2A (0.50) MAOAMAOBKMT2AMAPTALDH1A1
SCHEMBL457313 0.74 TDP1 (0.56) MAOAMAOBKMT2AMAPTALDH1A1
SCHEMBL454941 0.74 ALDH1A1 (0.46) MAOBKMT2AMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed